Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_assertion type Assertion NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_head.
- NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_assertion description "[In parallel, data obtained in a primary breast cancer clinical series showed that disease-free survival was shorter in individuals bearing the CCR5Delta32 allele than in CCR5 wild-type patients, but only for those whose tumors expressed wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_provenance.
- NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_assertion evidence source_evidence_literature NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_provenance.
- NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_assertion SIO_000772 14597737 NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_provenance.
- NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_assertion wasDerivedFrom befree-2016 NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_provenance.
- NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_assertion wasGeneratedBy ECO_0000203 NP419146.RA3LoUhlgtMO5BuXD4auqoNB7i353PVvRm_TAeTmNaiCM130_provenance.